🐋 SANM $5.7M Short Call Stack — Whale Sells Upside Into April 27 Earnings

📅 April 16, 2026 | 🔥 Unusual Options Activity Detected

---

🎯 The Quick Take

Someone just sold $5.7 MILLION worth of SANM calls this morning — two separate strikes, same expiration, same timestamp — capping the upside on Sanmina Corporation 11 days before the company's most important earnings print of the year. The $160 strike is already in-the-money by roughly $6, and the $175 strike sits $9 above the spot, making this a deliberate short call stack that either collects premium on an existing long position or is an outright bet that SANM does not break out before the May 15 expiration. With Q2 earnings expected April 27-28 and the street still nursing wounds from a 22% single-session drop in March, whoever sold these calls is telling you exactly what they think: the ceiling is low and the risk is up here.

---

📊 Company Overview

Sanmina Corporation (NASDAQ: SANM) is one of the largest U.S.-listed Electronics Manufacturing Services (EMS) providers, now repositioned squarely inside the AI infrastructure supply chain following its October 2025 acquisition of ZT Systems' data center manufacturing business from AMD.

• Market Cap: ~$8.43 billion
• Exchange: NASDAQ
• Industry: Electronics Manufacturing Services (EMS)
• Primary Business: End-to-end manufacturing for communications, cloud/AI infrastructure, industrial, medical, and defense markets — including PCB fabrication, mechanical systems, assembly, test, and aftermarket services
• Key Development: The ZT Systems acquisition adds ~$5-6B annual revenue run-rate and makes Sanmina AMD's preferred U.S.-based NPI manufacturing partner for cloud rack and cluster-scale AI solutions. Communications, cloud, and AI is now 62% of revenue, up from 37% a year ago.

---

💰 The Option Flow Breakdown

The Tape — April 16, 2026 @ 11:54:01:

Total premium collected: $5.7M

🤓 What This Actually Means

Two calls, same timestamp, same expiration — this was placed as a coordinated block. Here is what the data tells us:

• 💸 $160 Call — ITM short ($18.15 per contract × 2,070 contracts × 100 = $3.8M): The $160 strike is approximately $5.94 in-the-money with spot at $165.94. Selling an ITM call this deep either caps income on a long stock position (covered call writing) or is an aggressive premium collection bet that SANM does not close the month much higher than here. The classifier tags this trade as STC (Sell-to-Close), Z-score 2.53 — meaningful unusual activity, consistent with a closing of an existing long call position and a roll into a short position.

• 💸 $175 Call — OTM short ($11.00 per contract × 1,710 contracts × 100 = $1.9M): The $175 strike sits $9.06 above spot — roughly 5.5% OTM. This one is flagged as STO (Sell-to-Open) with a Z-score of 463 against an OI of only 18 contracts. Translation: this is a brand new short position opened against essentially no existing open interest — 1,710 contracts on an OI of 18 is roughly 95x the prior interest. That is not a hedge. That is a conviction trade on SANM not breaching $175 by May 15.

• 📊 Net premium collected $5.7M across two strikes creates a natural range trade: the short $160 call profits if the stock stays near or below $160, while the short $175 call allows the stock to drift to $175 before it bites. Together, they define the trader's view: SANM will not rip above $175 in the next 29 days, and any rally toward $170-$175 is a selling opportunity.

Structural read: The most probable interpretation is a two-legged short call spread or ladder on top of a long stock position (covered call writing at two strikes), collecting $5.7M in premium ahead of a binary earnings event. If spot is $165.94 and you are short the $160 call, you are effectively surrendering stock upside above $160 in exchange for the $18.15 premium. Add the $175 short call as a second tier and you have a staggered ceiling structure.

---

📈 Technical Setup

YTD Performance Chart

SANM has delivered a +83% gain over the trailing twelve months, but that headline masks a violent March: shares plunged 20-22% in a single session on March 12, 2026 after Q2 guidance came in $250M below the Street consensus midpoint. The stock has been clawing back since, crossing its 200-day moving average (~$146) on April 14, 2026 — a constructive technical signal. Current spot $165.94 puts the stock +13.4% from that 200DMA and right in the middle of the gamma battleground heading into earnings.

Key observations:

• 📈 200DMA reclaim April 14 — first confirmed close above that level since the March crash; often signals early-stage recovery
• ⚠️ March crash scar at ~$120-$125 remains the worst-case reversion level if earnings disappoint again
• 🎢 High vol regime: The +83% TTM performance alongside a -22% single-day drop shows this stock swings hard in both directions
• 🔄 Partial recovery: From the March low to today's $166, the stock has recovered roughly 40% of the crash. Full recovery to pre-crash levels ($195-$200) requires a clean Q2 print.

Gamma-Based Support & Resistance Analysis

Current Price: $165.94

The gamma exposure map for SANM shows a concentrated call gamma wall at $160 and meaningful resistance at $170 and $175 — aligning almost exactly with where today's trades were struck.

🔵 Support Levels (Put Gamma Below Price):

• $165 — Immediate support; largest total GEX below spot (0.074B units). Spot is sitting on top of this level right now — a break below it removes the nearest floor.
• $160 — Strong structural support at 0.845B total GEX — the single heaviest gamma concentration in the support stack. Market makers are significantly long gamma here, providing mechanical buying on dips toward $160. Notably, this is also where the ITM short call was struck.
• $155 — Secondary support at 0.048B total GEX (6.5% below spot)
• $150 — Moderate support at 0.018B total GEX
• $145 — Deeper floor at 0.123B total GEX (12.5% below spot) — aligns with JPMorgan's $145 price target

🟠 Resistance Levels (Call Gamma Above Price):

• $170 — Nearest overhead ceiling at 0.035B total GEX; only 2.5% above spot. Dealers will sell into strength here.
• $175 — Second resistance tier at 0.093B total GEX (5.6% above spot) — this is exactly where the second short call was placed. The trader's short $175 strike and the gamma resistance at $175 are perfectly aligned.
• $180 — Extended resistance at 0.039B total GEX (8.6% above spot)
• $185 — Light resistance at 0.015B total GEX

Net GEX Bias: Bullish (1.27B call GEX vs. 0.14B put GEX) — overall dealer positioning skews toward supporting price via gamma hedging, but the call walls at $170 and $175 create natural selling pressure on rallies.

What this means: The stock is essentially sandwiched between $165 support and $170 resistance in the near term. The short call trader has placed one strike at the strongest support level ($160) and the other at the second resistance tier ($175) — using the gamma map as a blueprint for where to sell premium.

Implied Move Analysis

Options market pricing for upcoming expirations (as of April 16, 2026):

• 📅 Weekly / Monthly OPEX (April 17 — 1 day): ±$5.12 (±3.07%) → Range: $161.95 - $172.19

The options market is pricing a 3% one-day swing for tomorrow's April 17 expiration. The implied range of $161.95-$172.19 neatly brackets both the $160 short call (inside the lower bound) and the $170 gamma wall. The short $175 call sits comfortably outside the implied move upper bound, giving the seller meaningful cushion for tomorrow's expiration.

More importantly for this trade: The May 15, 2026 expiration is 29 days out and captures Q2 earnings on approximately April 27-28. Historical EMS earnings moves for SANM have been substantial — the March post-guidance session was -22% on its own. The implied move for the May expiry is not directly quoted here, but at $160/$175 strikes versus a spot of $165.94, the seller is accepting risk if SANM surges more than $9 (5.4%) above today's price. Given the company's own Q2 guidance of $3.1-$3.4B vs. the $3.5B Street consensus, a blowout beat that drives a 5%+ rally is possible but is not the base case.

---

🎪 Catalyst Context

🔥 Primary Catalyst — Q2 FY2026 Earnings (~April 27-28, 2026)

This is the event the entire trade is built around. Q2 FY2026 earnings are estimated for April 27-28, 11 days from today and squarely inside the May 15 expiration window.

The setup heading in:

• Company Q2 guidance: Revenue $3.1-$3.4B; non-GAAP EPS $2.25-$2.55; non-GAAP operating margin 5.7-6.2% (per MarketBeat)
• Street consensus: ~$3.5B revenue — meaningfully above the company's own range
• The gap: Sanmina's high-end guide is $100M below what the street is modeling. The company needs to at minimum confirm the top end ($3.4B) and offer credible color on ZT Systems integration to avoid a repeat of the March selloff

Why this matters for the short call seller: A guidance miss would send SANM lower, making both short calls worthless and the full $5.7M collected. A blowout beat that drives stock above $175 creates unlimited upside losses on the naked $175 short call (or requires stock delivery on the $160 covered position). The seller is pricing in: earnings clears, but the rally is capped.

📋 Recent History — Q1 FY2026 Double Beat (January 26, 2026)

The most recent print was strong: Q1 revenue of $3.19B (+59% YoY) and non-GAAP EPS of $2.38 beat consensus (~$2.14 expected). The beat on both lines was clear. The problem was the Q2 guide — and the market punished it mercilessly, sending shares down 20-22% on March 12 the day the guidance disappointment registered.

🏢 ZT Systems Acquisition — The AMD Partnership

The October 27, 2025 close of the ZT Systems data center manufacturing acquisition from AMD for up to $3.0B is the strategic pivot that transformed Sanmina's revenue profile. ZT Systems manufactures AI rack and cluster-scale infrastructure — the physical servers and networking fabric that hyperscalers deploy for AI training and inference. Sanmina becomes AMD's preferred NPI partner in the U.S., plugged directly into the AMD MI-series GPU deployment cadence. The AI/cloud segment is now 62% of total revenue; core Sanmina (ex-ZT) in this segment grew ~20% YoY in Q1.

🏦 Analyst Landscape

• JPMorgan initiated at Neutral with $145 price target (March 30, 2026) — the most bearish voice in the room, citing cyclical industrial exposure and slower margin expansion vs. peers
• Bank of America raised its price target to $190 — the most bullish among active coverage
• Argus raised its PT by $30 — constructive on the ZT integration thesis
• Zacks downgraded to Hold (March 30) and Weiss downgraded to Hold (April 1) — two rating actions in 30 days reflecting skepticism post-March
• Median consensus PT: ~$190, range $145-$200 — the stock at $166 sits at a 12% discount to the median target and a 14% premium to JPMorgan's floor

---

🎲 Bull and Bear Cases

📈 Bull Case — Q2 Delivers, Short Calls Get Tested

Target: $175-$190

If Q2 revenue prints at or above $3.4B (the high end of company guidance), ZT Systems integration costs are trending lower, and management offers any increase to full-year outlook, the stock has room to close toward BofA's $190 target. At $165.94 today, a 15% move to $190 would blow through both short call strikes. The seller's short $175 call would move deep in-the-money, and losses would be unlimited above $175 if the position is naked. The $160 strike — if covered — would simply cap stock gains above $178.15 (strike + premium received).

Key drivers for the bull case:

• ✅ Q2 revenue at or above $3.4B, above Street's fears
• ✅ ZT integration cost trajectory improving; margin at or above 6%
• ✅ Communications/cloud/AI growth ex-ZT continues at ~20% YoY
• ✅ AMD AI rack volume ramp confirmed for 2H calendar 2026
• ✅ FY2026 EPS estimate ~$10.19, up 46% since April 2025 — if confirmed, stock is trading at ~16x forward, a discount to peers

Probability: 25-30% — requires execution above the guided range AND credible forward color.

📉 Bear Case — Guidance Disappoints Again

Target: $130-$145

A repeat of the March 12 playbook would be devastating. If Q2 revenue prints below $3.1B (below the company's own guide) or Q3 guidance again undershoots consensus, the stock could re-test pre-200DMA levels near $145 (JPMorgan's target) or worse. The $145 GEX support level and JPMorgan's $145 PT converge as the logical floor in a re-selloff scenario.

Key drivers for the bear case:

• ❌ Q2 revenue below $3.25B (guidance midpoint), flagging persistent ZT integration drag
• ❌ Non-GAAP operating margin below 5.7%, implying dilution is worse than guided
• ❌ Industrial segment (-3% YoY in Q1) shows no signs of recovery
• ❌ Insider selling continues — insiders have trimmed into the recovery
• ❌ Celestica raised its 2026 revenue outlook to $17B during the same period; competitive contrast hurts sentiment

Probability: 30-35% — the market is already skeptical, and Q2 guidance was deliberately conservative. But "below guidance" remains a live risk given the ZT integration complexity.

🎯 Base Case — Muddle Through, Short Calls Expire Worthless

Target: $155-$170 range

The most likely scenario: SANM reports Q2 in-line to slightly below consensus but within the guided range, management provides cautious-but-stable Q3 color, and the stock trades sideways to slightly lower. The $160 and $175 short calls both expire out-of-the-money or near-the-money, and the seller keeps the bulk of the $5.7M premium. This is a reasonable outcome given:

• The company's own guidance midpoint ($3.25B) is the most likely Q2 revenue outcome
• The $165 GEX support holds as long as sentiment does not deteriorate materially
• The gamma wall at $170 caps near-term rallies even on a mild beat

Probability: 40-45% — the base case rewards the short call seller and is consistent with how the stock has been trading post-March.

---

💡 Trading Ideas

🛡️ Conservative — Wait for Earnings Clarity

Play: Do not initiate new positions before April 27-28. This is a binary event with outsized historical moves (-22% in March, potential for a comparable swing in either direction).

Why this works:

• ⏰ Implied volatility will be elevated into the print; options premiums are expensive. Wait for the IV crush post-earnings before entering any new spread
• 📊 The short call seller is a professional playing a defined-risk income trade. Retail traders trying to front-run this setup may be on the wrong side if earnings surprise
• 🎯 Post-earnings, look for SANM to settle near the $160-$165 gamma support zone if results are in-line — that would be a higher-quality entry for a long position
• 👀 Watch for Q2 revenue vs. $3.25B guidance midpoint as the single most important data point

Risk level: Minimal | Best for: Patient swing traders unwilling to take binary earnings risk

⚖️ Balanced — Post-Earnings Covered Call Replication

Play: After earnings, if SANM pulls back toward $155-$160, sell a May or June $175 call against a long stock position — essentially replicating the $175 short call leg of today's trade at a better entry

Why this works:

• 📈 If stock drops to $160 post-earnings (in-line or slight miss), you enter the stock at support with a natural covered call income layer
• 💰 IV crush after earnings makes call premiums cheaper in absolute terms but still meaningful given the upcoming AMD rack ramp narrative
• 🎯 $175 remains the gamma resistance ceiling — selling calls at that level has mechanical support from dealer positioning
• 📅 May 15 expiration captures the post-earnings settling period; June 19 gives more runway if Q3 guidance creates overhang

Estimated structure:

• Buy stock near $158-$162 (post-earnings dip scenario)
• Sell $175 calls (May 15 or June 19 expiry) — collect $8-$12 per contract depending on IV
• Effective cost basis: $146-$154, protected downside to $145 (JPMorgan target)

Risk level: Moderate | Best for: Longer-term stock holders who want income while waiting for the ZT Systems story to fully play out

🚀 Aggressive — Short Call Spread Ahead of Earnings (ADVANCED ONLY)

Play: Sell a call spread — short the $175 call, buy the $185 call — for the May 15 expiration, capturing a portion of the short call seller's thesis with defined upside risk

Why this could work:

• The $175 call had a Z-score of 463 and was opened against near-zero OI — this is a strong conviction signal that a large player does not expect SANM to breach $175 by May 15
• The gamma wall at $175 reinforces the resistance thesis
• Earnings guidance is likely to disappoint vs. the $3.5B Street number, capping any rally

Estimated structure:

• Sell $175 call (May 15): ~$11-$13 premium
• Buy $185 call (May 15): ~$5-$7 premium (cap your unlimited upside risk)
• Net credit: ~$5-$7 per spread, max risk $10 (the spread width)
• Breakeven: $180-$182 (spread credit subtracted from $185 cap)
• Max profit: Keep full credit if SANM below $175 at May 15

CRITICAL WARNING: If SANM beats Q2 consensus badly and gaps above $185, this spread loses its maximum of $10 ($1,000 per spread). Never enter without the long $185 call leg. Never size larger than 2-3% of portfolio. This is a directional earnings bet with binary event risk.

Risk level: EXTREME before earnings | Best for: Experienced spread traders only who understand earnings vol risk

---

⚠️ Risk Factors

• ⏰ Earnings binary (April 27-28): The May 15 expiration wraps both legs directly around the Q2 print. SANM has shown it can move 20%+ on a single earnings session. The short $175 call creates unlimited upside loss exposure above $175 if the position is not covered by stock. This is the number-one risk for anyone copying this trade structure without a long stock position underneath.

• 📊 Q2 guidance gap vs. consensus: The company guided $3.1-$3.4B; consensus is $3.5B. Even if SANM hits the top of its own range at $3.4B, it still misses the Street by $100M. The market may react negatively to an "in-line with guidance" print because the Street was positioned higher. This is the March 12 scenario playing out again.

• 🏢 ZT Systems integration complexity: This is a $3B acquisition of a hyperscaler-serving infrastructure manufacturer. Integration disruptions, margin dilution in the transition period, and ramp delays in legacy industrial programs (medical, defense, energy) are all live risks that management flagged themselves in the guidance call.

• 👤 Insider selling: Multiple insiders have trimmed positions during the post-January recovery. This is not a panic signal by itself, but it is directionally worth noting as the stock approaches the $165-$170 zone.

• 🏦 Analyst de-rating cluster: JPMorgan Neutral at $145 (March 30), Zacks downgraded to Hold (March 30), Weiss downgraded to Hold (April 1) — three downgrades in 30 days create a credibility headwind for the recovery narrative going into Q2.

• 🌍 China tariff exposure: Sanmina maintains manufacturing capacity in China that remains exposed to ongoing U.S. tariffs. A year after the April 2, 2025 tariff announcement, tariffs have settled near 10% under Section 122, but further escalation would directly pressure cost of goods sold.

• 🏭 Customer concentration: Top 10 customers represent 52% of revenue; one customer is above 10%. Any hyperscaler capex pause or insourcing decision is a concentrated revenue risk, not an industry-wide headwind.

• 🥊 Competitive pressure from Celestica: Celestica raised its 2026 revenue outlook to $17B in the same quarter SANM disappointed — that contrast was part of what hammered SANM in March. Celestica is winning in 800G AI networking and Jabil is pivoting aggressively into AI solutions. SANM is not the only EMS play, and investors have shown they will rotate quickly.

---

🎯 The Bottom Line

Real talk: Whoever sold $5.7M in SANM calls this morning is not panicking — they are collecting rent. The two-strike short call structure at $160 and $175 tells a very specific story: spot goes nowhere fast, earnings are good-not-great, and the market does not reward SANM with a breakout above $175 in the next 29 days.

The thesis is defensible. Q2 guidance of $3.1-$3.4B already sits below the $3.5B Street consensus, and after the March selloff the buy-side has a low tolerance for another miss. The gamma wall at $170-$175 provides structural reinforcement for the ceiling thesis. And the $5.7M premium buffer gives the seller significant cushion even if the stock drifts modestly higher.

What this trade tells us:

• 🎯 A large player has decided the risk/reward above $175 is not worth holding uncapped upside exposure into earnings
• 💰 Net premium of $5.7M collected implies the seller needs SANM to stay below the short strikes to profit — they are not bearish on the stock, just bearish on a breakout
• 📊 The Z-score of 463 on the $175 strike (opened against OI of 18!) is the loudest signal — this is a conviction new position, not routine hedging
• 🗓️ May 15 expiration captures everything: Q2 print April 27-28, analyst reactions, and any Q3 guidance revision

If you own SANM:

• ✅ The covered call framework (selling $175 calls against a long position) is the cleanest read on this trade — earning premium while waiting for the ZT Systems story to fully materialize
• 📊 If earnings are solid, the stock may test $170-$175 and the short calls will be tested; be prepared for that outcome if replicating this structure
• ⏰ Do not enter any new long positions ahead of the April 27-28 print without acknowledging the March 12 precedent — the stock can drop 20% on a guidance miss

If you are watching from the sidelines:

• 📅 April 27-28 is the only date that matters right now — watch Q2 revenue vs. $3.25B guidance midpoint and Q3 guide vs. Street
• 🎯 A post-earnings dip toward $155-$160 (the strongest gamma support) would be the cleanest long entry for the ZT Systems narrative at a reasonable risk/reward
• 🚀 A clean beat and raise that pushes stock above $175 would confirm the full recovery from March; at that point, the $190 BofA target becomes relevant

If you are bearish:

• 📉 The $145-$150 zone is where JPMorgan's target and gamma support converge — a guidance disappointment could re-test that level within days of earnings
• 🎯 Post-earnings put spreads (buying $155/$145 put spread after IV crush) offer a defined-risk way to play the downside without fighting the pre-earnings vol premium

Mark your calendar:

• 📅 April 17 — Weekly/Monthly OPEX; implied move ±$5.12 (±3.07%), range $161.95-$172.19
• 📅 April 27-28 — Q2 FY2026 earnings (THE catalyst)
• 📅 May 15 — Expiration of both short call positions from today's trade
• 📅 Late July 2026 — Q3 FY2026 earnings expected

Final verdict: The $5.7M short call stack is a clear premium collection trade by a large player who thinks SANM's near-term upside is capped heading into an uncertain earnings print. The call seller's view is not "this stock goes down" — it is "this stock does not go above $175 in 29 days, and I get paid $5.7M for being right." With gamma resistance stacked at $170 and $175, the March selloff still fresh in market memory, and Q2 guidance already below consensus, that is a reasonable bet. But the ZT Systems story and AMD AI rack ramp are real. If the Q2 print surprises to the upside, SANM and this trade will be under pressure fast.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. Past unusual options activity does not guarantee future directional outcomes. Selling uncovered call options involves theoretically unlimited risk and requires substantial margin and trading experience. The Z-score and unusual classification reflect statistical deviation from recent historical averages for this ticker — not a prediction of the trade's profitability. Always conduct your own research and consult a licensed financial advisor before making any investment decisions.

---

About Sanmina Corporation: Sanmina Corporation is a global electronics manufacturing services provider offering integrated solutions across design, manufacturing, assembly, test, and aftermarket services for communications, cloud/AI infrastructure, industrial, medical, defense, and automotive markets. Following the October 2025 acquisition of ZT Systems' data center manufacturing business from AMD, Sanmina's market cap is approximately $8.43 billion on NASDAQ (SANM), with AI/cloud infrastructure now representing 62% of company revenue.